Bethany J. Cavanagh, SVP of Finance and Treasurer at Beam Therapeutics Inc. ($BEAM), sold shares on the open market four times over the past year for a total of $375 thousand. Her latest sale occurred on January 22, 2026. These Beam Therapeutics insider sales rank her 7,086th out of 11,678 individuals in our database, well below the average of $8.6 million per insider and 6.4 transactions. Cavanagh made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Common Stock | 20000 | $0.00 | 54,813.0000 | 102,570,801 | 57.45% | 0.02% |
| Jan. 31, 2026 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 102,570,801 | 9999.99% | 0.04% |
| Jan. 22, 2026 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 6198 | $35.00 | 34,813.0000 | 102,570,801 | 15.11% | 0.01% |
| Jan. 20, 2026 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 3034 | $30.12 | 41,011.0000 | 102,570,801 | 6.89% | 0.00% |
| Oct. 1, 2025 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 467 | $24.53 | 44,045.0000 | 102,570,801 | 1.05% | 0.00% |
| April 1, 2025 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 3015 | $18.35 | 44,512.0000 | 82,313,008 | 6.34% | 0.00% |
| March 31, 2025 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Common Stock | 10000 | $0.00 | 47,527.0000 | 82,313,008 | 26.65% | 0.01% |
| Feb. 18, 2025 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 6287 | $35.00 | 37,527.0000 | 82,313,008 | 14.35% | 0.01% |
| Jan. 31, 2025 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 82,313,008 | 9999.99% | 0.02% |
| Jan. 2, 2025 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 1117 | $24.68 | 43,814.0000 | 82,313,008 | 2.49% | 0.00% |
| Oct. 1, 2024 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 289 | $23.48 | 44,931.0000 | 82,410,095 | 0.64% | 0.00% |
| Sept. 30, 2024 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Common Stock | 2500 | $0.00 | 45,220.0000 | 77,151,771 | 5.85% | 0.00% |
| Aug. 31, 2024 | Beam Therapeutics Inc. | $BEAM | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 77,151,771 | 9999.99% | 0.01% |